HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annika Hansen Selected Research

M3258

10/2021Improved nonclinical safety profile of a novel, highly selective inhibitor of the immunoproteasome subunit LMP7 (M3258).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annika Hansen Research Topics

Disease

1Multiple Myeloma
10/2021
1Hematologic Neoplasms (Hematological Malignancy)
10/2021
1Neoplasms (Cancer)
10/2021
1Alcoholism (Alcohol Abuse)
01/2021

Drug/Important Bio-Agent (IBA)

1Peptide Hydrolases (Proteases)FDA Link
10/2021
1M3258IBA
10/2021

Therapy/Procedure

1Aftercare (After-Treatment)
01/2021